BioSerenity
15
0
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
33.3%
5 terminated/withdrawn out of 15 trials
58.3%
-28.2% vs industry average
0%
0 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Maternal-Fetal Monitoring by Connected Abdominal Patch - MOMA
Role: collaborator
REtinal and VIsual Cortical Response in Early PSYchosis
Role: collaborator
Study of Bipolar Disorders and Retinal Electrophysiological Markers
Role: collaborator
PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study
Role: collaborator
Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions
Role: lead
Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors
Role: collaborator
Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital
Role: lead
Evaluation of the Signals Electrophysiological Measured by Intelligent Textiles
Role: lead
Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH)
Role: lead
Collection of Information by Tocography External
Role: lead
Clinical Trial Testing the BioSerenity Pulse Oximeter (EOXY) Efficacy, Performance and Safety in Healthy Volunteer
Role: lead
Monitoring of Regional Lung Ventilation by Chest Electrical Impedance in the Course of Extubation
Role: lead
EVAluation of the Non Inferiority of Interpretability of Cardiokin Compared to Holter
Role: lead
evaluatioN de la perfOrMAnce De Capteurs E-textiles
Role: lead
Evaluation of Electrophysiological Signal Measured by Smart Textile CE-marked
Role: lead
All 15 trials loaded